Newtyn Management, LLC Io Biotech, Inc. Transaction History

Newtyn Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.88 - $2.98 $76,429 - $121,148	-40,654 Reduced 45.17%	49,346 $92,000
Q4 2022 Feb 14, 2023	SELL	$2.22 - $3.1 $22,200 - $31,000	-10,000 Reduced 10.0%	90,000 $206,000
Q3 2022 Nov 14, 2022	BUY	$2.51 - $4.85 $250,999 - $484,999	100,000 New	100,000 $271,000

23.6M

Ticker IOBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,815,300
Market Cap $23.6M
Description
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Newtyn Management, LLC with notifications on news.